These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3538499)

  • 1. Historical background of 6-mercaptopurine.
    Elion GB
    Toxicol Ind Health; 1986 Sep; 2(2):1-9. PubMed ID: 3538499
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of action of 6-mercaptopurine and thioinosine, and clinical effects of the agents].
    Nakamura T
    Naika Hokan; 1970 Oct; 17(10):375-84. PubMed ID: 5529422
    [No Abstract]   [Full Text] [Related]  

  • 3. [Targets of antileukemia agents: molecular mechanisms of mercaptopurine action].
    Krynetskaia NF; Krynetskiĭ EIu
    Mol Biol (Mosk); 2000; 34(6):1046-53. PubMed ID: 11186004
    [No Abstract]   [Full Text] [Related]  

  • 4. The early history of chemical immunosuppression: 1900-1965.
    Glassock RJ
    J Nephrol; 2006; 19 Suppl 10():S132-6. PubMed ID: 16874727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Progress in the field of hematology in the last 100 years: Medical history of acute leukemia].
    Ono R
    Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):2084-9. PubMed ID: 12187682
    [No Abstract]   [Full Text] [Related]  

  • 6. Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemia.
    Ellison RR; Hoogstraten B; Holland JF; Levy RN; Lee SL; Silver RT; Leone LA; Cooper T; Oberfield RA; Ten Pas A; Blom J; Jacquillat C; Haurani F
    Cancer Chemother Rep; 1972 Aug; 56(4):535-42. PubMed ID: 4507688
    [No Abstract]   [Full Text] [Related]  

  • 7. Childhood leukaemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropenia. 1983.
    Lennard L; Rees CA; Lilleyman JS; Maddocks JL
    Br J Clin Pharmacol; 2004 Dec; 58(7):S867-71; discussion S872-4. PubMed ID: 15595985
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.
    Korelitz BI
    Gastroenterologist; 1995 Jun; 3(2):141-52. PubMed ID: 7640945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
    Sandborn WJ
    Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of hydrocortisone and 6-mercaptopurine on liver tissue in the course of experimental intoxication of rabbits with CCl4.
    Boroń P; Musiatowicz B; Prokopowicz D; Strugacz J
    Z Mikrosk Anat Forsch; 1974; 88(3):576-80. PubMed ID: 4450637
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytostatics in hematology].
    Gross R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(3):109-28. PubMed ID: 4114893
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination therapy with 6-mercaptopurine (NSC-755) and allopurinol (NSC-1390) during induction and maintenance of remission of acute leukemia in children.
    Levine AS; Sharp HL; Mitchell J; Krivit W; Nesbit ME
    Cancer Chemother Rep; 1969 Feb; 53(1):53-7. PubMed ID: 5772655
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged remission following acute stem cell leukemia treated with 6-mercaptopurine and prednisone.
    Pinkhas J; Mintz U; de Vries A
    New Istanbul Contrib Clin Sci; 1974 Jun; 11(1):39-42. PubMed ID: 4444932
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of 6-mercaptopurine on Giardia intestinalis.
    Mukherjea AK; Chatterjea JB
    Bull Calcutta Sch Trop Med; 1966 Oct; 14(4):121. PubMed ID: 5252549
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of the antitumor effect of 6-mercaptopurine by vitamin A.
    Akiyama S; Masuda A; Tabuki T; Kuwano M; Komiyama S
    Gan; 1981 Oct; 72(5):742-6. PubMed ID: 7199007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of acute leukemia in childhood. Comparison of cyclophosphamide and mercaptopurine.
    Fernbach DJ; Griffith KM; Haggard ME; Holcomb TM; Sutow WW; Vietti TJ; Windmiller J
    N Engl J Med; 1966 Sep; 275(9):451-6. PubMed ID: 5917939
    [No Abstract]   [Full Text] [Related]  

  • 17. A practical guide to the use of thiopurines in oral medicine.
    Hullah EA; Blaker PA; Marinaki AM; Escudier MP; Sanderson JD
    J Oral Pathol Med; 2015 Nov; 44(10):761-8. PubMed ID: 25529219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the primary immune response in man by anti-metabolites.
    Hersh EM; Carbone PP; Wong VG; Freireich EJ
    Cancer Res; 1965 Aug; 25(7):997-1001. PubMed ID: 5843275
    [No Abstract]   [Full Text] [Related]  

  • 19. Gold nanoparticles enhance the anti-leukemia action of a 6-mercaptopurine chemotherapeutic agent.
    Podsiadlo P; Sinani VA; Bahng JH; Kam NW; Lee J; Kotov NA
    Langmuir; 2008 Jan; 24(2):568-74. PubMed ID: 18052300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Various immunological approaches to the control, treatment and prevention of leukaemia.
    Mathé G
    Bibl Haematol; 1973; 39():1220-6. PubMed ID: 4798251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.